Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
John R. Power(UC San Diego Health System), Joe‐Elie Salem(Inserm), Javid J. Moslehi(Cardiovascular Institute of the South), Shi Huang(Vanderbilt University Medical Center), Anita Deswal(The University of Texas MD Anderson Cancer Center), Nicolas L. Palaskas(The University of Texas MD Anderson Cancer Center), Lauren Gilstrap(Dartmouth College), Dimitri Arangalage, Stéphane Éderhy, Jennifer Cautela(Hôpital Nord), Lorenz Lehman(Heidelberg University), Salim S. Hayek(Rush University Medical Center), Franck Thuny(Assistance Publique Hôpitaux de Marseille), Aarti Asnani(Beth Israel Deaconess Medical Center), Yuichi Tamura(Kanazawa Hospital), Steven M. Ewer(UW Health University Hospital), Joachim Alexandre(Government of the United States of America), Arrush Choudhary(Beth Israel Deaconess Medical Center), Daniel Finke(Heidelberg University), Mandar A. Aras(University of California San Francisco Medical Center), Benay Özbay(University of Pittsburgh Medical Center)
Cited by 14
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k